This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, S. Articles by Wasik, M. A. Search for Related Content PubMed PubMed Citation Articles by Li, S. Articles by Wasik, M. A.

(American Journal of Pathology. 2001;158:1231-1237.)
© 2001 American Society for Investigative Pathology

Short Communications

Comparative Genome-Scale Analysis of Gene Expression Profiles in T Cell Lymphoma Cells during Malignant Progression Using a Complementary DNA Microarray

Shiyong Li^*, Douglas T. Ross, Marshall E. Kadin, Patrick O. Brown and Mariusz A. Wasik^*

From the Department of Pathology and Laboratory Medicine,^*
University of Pennsylvania Medical Center, Philadelphia, Pennsylvania; the Department of Biochemistry and Howard Hughes Medical Institute,
Stanford University School of Medicine, Stanford, California; and the Department of Pathology,
Beth Israel-Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts

Using a cDNA microarray, we compared the expression of approximately 8000 genes between two unique, clonally related T cell lines derived from different stages of a progressive T cell lymphoma involving skin. A total of 180 genes was found to be differentially expressed at the RNA level by a factor of fivefold or greater. Compared with the cells from the earlier, clinically indolent stage of the lymphoma, 56 genes were up-regulated, whereas 124 genes were down-regulated in the cells from the advanced, clinically aggressive stage lymphoma. The functions of approximately 65% of these genes are currently unknown. The 22 genes with a known function that were up-regulated in the advanced lymphoma cells included several genes involved in promotion of cell proliferation and survival as well as drug resistance. The 42 functionally characterized genes that were down-regulated in the advanced lymphoma cells included negative regulators of cell activation and cell cycle, and mediators of cell adhesion, apoptosis, and genome integrity. The differential expression identified by the cDNA microarray analysis was confirmed for selected genes by reverse transcription-polymerase chain reaction and Northern blotting. The identified differences in gene expression may be related to the differences in behavior between the early and advanced stages of the T cell lymphoma and point to directions for further investigations into mechanisms of lymphoma progression.

This article has been cited by other articles:

				L. Lamant, A. d. Reynies, M.-M. Duplantier, D. S. Rickman, F. Sabourdy, S. Giuriato, L. Brugieres, P. Gaulard, E. Espinos, and G. Delsol Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes Blood, March 1, 2007; 109(5): 2156 - 2164. [Abstract] [Full Text] [PDF]

				B. Martinez-Delgado, B. Melendez, M. Cuadros, J. Alvarez, J. M. Castrillo, A. Ruiz de la Parte, M. Mollejo, C. Bellas, R. Diaz, L. Lombardia, et al. Expression Profiling of T-Cell Lymphomas Differentiates Peripheral and Lymphoblastic Lymphomas and Defines Survival Related Genes Clin. Cancer Res., August 1, 2004; 10(15): 4971 - 4982. [Abstract] [Full Text] [PDF]

				S D Jenson, R S Robetorye, S D Bohling, J A Schumacher, J W Morgan, M S Lim, and K S J Elenitoba-Johnson Validation of cDNA microarray gene expression data obtained from linearly amplified RNA Mol. Pathol., December 1, 2003; 56(6): 307 - 312. [Abstract] [Full Text] [PDF]

				J. Willers, R. Dummer, W. Kempf, T. Kundig, G. Burg, and M. E. Kadin Proliferation of CD30+ T-Helper 2 Lymphoma Cells Can Be Inhibited by CD30 Receptor Cross-Linking with Recombinant CD30 Ligand Clin. Cancer Res., July 1, 2003; 9(7): 2744 - 2754. [Abstract] [Full Text] [PDF]

				C. Palena, J. Schlom, and K.-Y. Tsang Differential Gene Expression Profiles in a Human T-cell Line Stimulated with a Tumor-associated Self-peptide versus an Enhancer Agonist Peptide Clin. Cancer Res., May 1, 2003; 9(5): 1616 - 1627. [Abstract] [Full Text] [PDF]

				R. S. Robetorye, S. D. Bohling, J. W. Morgan, G. C. Fillmore, M. S. Lim, and K. S. J. Elenitoba-Johnson Microarray Analysis of B-Cell Lymphoma Cell Lines with the t(14;18) J. Mol. Diagn., August 1, 2002; 4(3): 123 - 136. [Abstract] [Full Text] [PDF]

				D. Arnott, A. Kishiyama, E. A. Luis, S. G. Ludlum, J. C. Marsters Jr., and J. T. Stults Selective Detection of Membrane Proteins Without Antibodies: A Mass Spectrometric Version of the Western Blot Mol. Cell. Proteomics, February 1, 2002; 1(2): 148 - 156. [Abstract] [Full Text] [PDF]

				J. L. Phillips, S. W. Hayward, Y. Wang, J. Vasselli, C. Pavlovich, H. Padilla-Nash, J. R. Pezullo, B. M. Ghadimi, G. D. Grossfeld, A. Rivera, et al. The Consequences of Chromosomal Aneuploidy on Gene Expression Profiles in a Cell Line Model for Prostate Carcinogenesis Cancer Res., November 1, 2001; 61(22): 8143 - 8149. [Abstract] [Full Text] [PDF]